1. Home
  2. AURA vs ATRO Comparison

AURA vs ATRO Comparison

Compare AURA & ATRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AURA
  • ATRO
  • Stock Information
  • Founded
  • AURA 2007
  • ATRO 1968
  • Country
  • AURA United States
  • ATRO United States
  • Employees
  • AURA N/A
  • ATRO N/A
  • Industry
  • AURA Biotechnology: Pharmaceutical Preparations
  • ATRO Military/Government/Technical
  • Sector
  • AURA Health Care
  • ATRO Industrials
  • Exchange
  • AURA Nasdaq
  • ATRO Nasdaq
  • Market Cap
  • AURA 572.0M
  • ATRO 634.4M
  • IPO Year
  • AURA 2021
  • ATRO N/A
  • Fundamental
  • Price
  • AURA $9.47
  • ATRO $16.54
  • Analyst Decision
  • AURA Strong Buy
  • ATRO Hold
  • Analyst Count
  • AURA 4
  • ATRO 1
  • Target Price
  • AURA $23.00
  • ATRO $20.00
  • AVG Volume (30 Days)
  • AURA 184.2K
  • ATRO 203.0K
  • Earning Date
  • AURA 11-12-2024
  • ATRO 11-06-2024
  • Dividend Yield
  • AURA N/A
  • ATRO N/A
  • EPS Growth
  • AURA N/A
  • ATRO N/A
  • EPS
  • AURA N/A
  • ATRO N/A
  • Revenue
  • AURA N/A
  • ATRO $782,178,000.00
  • Revenue This Year
  • AURA N/A
  • ATRO $15.70
  • Revenue Next Year
  • AURA N/A
  • ATRO $6.98
  • P/E Ratio
  • AURA N/A
  • ATRO N/A
  • Revenue Growth
  • AURA N/A
  • ATRO 19.95
  • 52 Week Low
  • AURA $6.63
  • ATRO $14.58
  • 52 Week High
  • AURA $12.38
  • ATRO $23.74
  • Technical
  • Relative Strength Index (RSI)
  • AURA 39.43
  • ATRO 37.70
  • Support Level
  • AURA $10.48
  • ATRO $17.87
  • Resistance Level
  • AURA $11.29
  • ATRO $17.24
  • Average True Range (ATR)
  • AURA 0.56
  • ATRO 0.85
  • MACD
  • AURA -0.18
  • ATRO -0.18
  • Stochastic Oscillator
  • AURA 2.67
  • ATRO 13.61

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its lead candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

About ATRO Astronics Corporation

Astronics Corp supplies products to the aerospace, defense, and electronics industries. The company has two reportable segments namely Aerospace and Test Systems. The aerospace segment serves three primary markets: military, commercial transport, and General Aviation. The Test Systems segment serves the aerospace, defense, and semiconductor markets. The company generates a majority of its revenue from the Aerospace segment. Geographically, it generates a majority of its revenue from the United States.

Share on Social Networks: